Top Factor Driving Rotavirus Vaccine Market Growth in 2025: Impact Of Rising Birth Rates On Rotavirus Vaccine Market Growth

How Big Is the Rotavirus Vaccine Market Expected to Be, and What Will Its Growth Rate Be?
The market size for the rotavirus vaccine has seen a significant expansion in the recent past. The sector, which is projected to ascend from $9.18 billion in 2024 to $10.14 billion in 2025, will experience a compound annual growth rate (CAGR) of 10.5%. Several factors have propelled the growth in this period including heightened understanding of rotavirus, enhanced healthcare facilities, government-backed immunization plans, increasing cases of rotavirus infections and a surge in birth rates.

The market size for rotavirus vaccine is anticipated to experience swift expansion in the forthcoming years. It is predicted to reach $14.96 billion in 2029 with a 10.2% compound annual growth rate (CAGR). The forecast period's growth can be credited to escalating birthrates, the broadening of immunization programs, amplified attention on preventative health, economic upturn and enhanced access, and beneficial government strategies and funding. Noteworthy trends forecasted for this period include progress in vaccine technology, evolution in oral-administered vaccines, better vaccine formulations, combined vaccines, and incorporation with digital health.

What Are the Primary Growth Drivers for the Rotavirus Vaccine Market?
The growth of the rotavirus vaccine market is anticipated to be driven by increasing birth rates. Birth rates, annually defined as the count of live births for every 1,000 individuals in a particular population span, are influenced by improved economic stability and growth as well as favorable policies including parental leave, child benefits, and subsidies for childcare. The administration of rotavirus vaccines aids in decreasing severe cases of rotavirus gastroenteritis in children, resulting in better child health results and decreased medical expenditures related to rotavirus infections. For example, in January 2023, a study by the Centers for Disease Control and Prevention, a public health organization in the US, showed a 1% rise in registered births which summed up to 3,664,292, a boost from the prior year. Hence, escalating birth rates are set to be a driving factor for the expansion of the rotavirus vaccine market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp

Who Are the Dominant Companies Influencing Rotavirus Vaccine Market Trends?
Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd., SK Chemicals Co Ltd., Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd

Who Are the Dominant Companies Influencing Market Trends?
In an effort to enhance vaccine delivery and increase patient compliance, major firms in the rotavirus vaccine market are beginning to utilize oral-dosing applicators. These are medical devices specifically created to dispense liquid medicines or vaccines directly into the oral cavity, ensuring proper dosage and user-friendliness, particularly for babies and young children. For example, GSK plc, a British pharmaceutical and biotech enterprise, got the green light from the United States Food and Drug Administration (FDA) in November 2022 for an oral-dosing applicator-only version of ROTARIX (Rotavirus Vaccine, Live, Oral). This liquid formula combats rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in infants. Not only does the new packaging prevent rotavirus gastroenteritis, but it also streamlines the vaccination process for healthcare providers by removing the requirement for dose reconstitution at the time of use.

What Are the Different Segmentations in the Rotavirus Vaccine Market?
The rotavirus vaccine market covered in this report is segmented -

1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types
2) By Application: Adult, Pediatric
3) By End Users: Hospitals, Clinics, Academic Research

Subsegments:
1) By Rotarix: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
2) By RotaTeq: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
3) By Rotavac: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
4) By Rotavin-M1: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
5) By Lanzhou Lamb: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
6) By Other Types: Emerging Rotavirus Vaccines, Combination Vaccines, Region-Specific Vaccines

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report

Which Region Is at the Forefront of the Rotavirus Vaccine Market?
North America was the largest region in the rotavirus vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Rotavirus Vaccine Global Market Report?

- Market Size Analysis: Analyze the rotavirus vaccine Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the rotavirus vaccine market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall rotavirus vaccine market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the rotavirus vaccine market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20617

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.